Diabetes mellitus: Plasticizers and nanomaterials acting as endocrine-disrupting chemicals (Review).

Various plasticizers and nanomaterials have been linked to endocrine disruptors or endocrine-disrupting chemicals (EDCs) which represent a large, heterogeneous, yet incompletely understood group of structures acting on normal and pathological body pathways such as hormonal production, secretion, transport and receptor binding. By contrast, various applications of nanoparticles are currently under investigation since the delivery of useful drugs, particularly insulin in diabetes mellitus, is essential in case of insulin deficiency. The aim of the present review was to introduce and examine different plasticizers and nanomaterials with potential applications for diabetic patients (such as selenium or gold-based nanoparticles that help the oral delivery of insulin) or plasticizers/nanomaterials acting similarly to EDCs in relation to the human and animal body, particularly glucose metabolism impairment such as diabetes mellitus (DM). Bisphenol A is a chemical used worldwide; however, the effect of exposure varies with regard to the source, environment, time of exposure and the age of the organism. Daily exposure is mostly related to food and drinks stored in polycarbonate plastics. However, exposure may also be through the skin or through the maternal placenta or breast milk which are risk factors for the fetus and for the newborn. It exerts an estrogen-like profile, but it also induces insulin resistance by impairing peripheral insulin receptors or it decreases insulin secretion by acting at the level of insulin-secreting pancreatic β-cells. Phthalates, compounds of flexible plastics, act as EDCs via their human metabolites such as diethyl phthalate and derivative monoethyl phthalate. Their role in inducing gestational DM and weight gain/obesity during pregnancy has been showcased. The vast field of plasticizers and nanomolecules acting as endocrine disruptors is widely linked to clinical aspects of DM, a serious condition with a major population impact. The importance of understanding and using these agents and applications is reflected in saving numerous human lives.

[1]  A. Stamatakis,et al.  Endocrine-disrupting chemicals and behaviour: A high risk to take? , 2021, Best practice & research. Clinical endocrinology & metabolism.

[2]  S. Kabekkodu,et al.  A comprehensive review on the carcinogenic potential of bisphenol A: clues and evidence , 2021, Environmental Science and Pollution Research.

[3]  N. Holland,et al.  Prenatal exposure to phthalates and maternal metabolic outcomes in a high-risk pregnant Latina population. , 2021, Environmental research.

[4]  C. Newgard,et al.  Mechanisms controlling pancreatic islet cell function in insulin secretion , 2021, Nature Reviews Molecular Cell Biology.

[5]  N. Pace,et al.  Bisphenol A and Type 2 Diabetes Mellitus: A Review of Epidemiologic, Functional, and Early Life Factors , 2021, International journal of environmental research and public health.

[6]  Yu-Hsiang Lee,et al.  Novel silver and nanoparticle-encapsulated growth factor co-loaded chitosan composite hydrogel with sustained antimicrobility and promoted biological properties for diabetic wound healing. , 2021, Materials science & engineering. C, Materials for biological applications.

[7]  K. Han,et al.  Potential Applications of Nanomaterials and Technology for Diabetic Wound Healing , 2020, International journal of nanomedicine.

[8]  M. Racchi,et al.  Endocrine-Disrupting Chemicals’ (EDCs) Effects on Tumour Microenvironment and Cancer Progression: Emerging Contribution of RACK1 , 2020, International journal of molecular sciences.

[9]  Gopal L. Khatik,et al.  An overview of computer-aided drug design tools and recent applications in designing of antidiabetic agents. , 2020, Current drug targets.

[10]  S. Bolduc,et al.  Endocrine-disrupting effects of bisphenols on urological cancers. , 2020, Environmental research.

[11]  C. O’Driscoll,et al.  Pre-clinical evaluation of a modified cyclodextrin-based nanoparticle for intestinal delivery of Liraglutide. , 2020, Journal of pharmaceutical sciences.

[12]  M. Goodarzi,et al.  Pathological Mechanisms in Diabetes of the Exocrine Pancreas: What’s Known and What’s to Know , 2020, Frontiers in Physiology.

[13]  A. Arbex,et al.  Endocrine Disruptors and the Induction of Insulin Resistance. , 2020, Current diabetes reviews.

[14]  Xiqiang Liu,et al.  Promote anti-inflammatory and angiogenesis using a hyaluronic acid-based hydrogel with miRNA-laden nanoparticles for chronic diabetic wound treatment. , 2020, International journal of biological macromolecules.

[15]  Laura N. Vandenberg,et al.  Update on the health effects of bisphenol A: Overwhelming evidence of harm. , 2020, Endocrinology.

[16]  M. Cârșote,et al.  Metabolic and cardiovascular benefits of GLP-1 agonists, besides the hypoglycemic effect (Review). , 2020, Experimental and therapeutic medicine.

[17]  L. Miranda-Alves,et al.  The impact of endocrine-disrupting chemical exposure in the mammalian hypothalamic-pituitary axis , 2020, Molecular and Cellular Endocrinology.

[18]  Wen-lan Sun,et al.  Maternal exposure to Di-n-butyl phthalate (DBP) aggravate gestational diabetes mellitus via FoxM1 suppression by pSTAT1 signalling. , 2020, Ecotoxicology and environmental safety.

[19]  R. Slama,et al.  Endocrine-disrupting chemicals: implications for human health. , 2020, The lancet. Diabetes & endocrinology.

[20]  A. Leone,et al.  Fetal–Maternal Exposure to Endocrine Disruptors: Correlation with Diet Intake and Pregnancy Outcomes , 2020, Nutrients.

[21]  P. Stepnowski,et al.  The quantification of bisphenols and their analogues in wastewaters and surface water by an improved solid-phase extraction gas chromatography/mass spectrometry method , 2020, Environmental Science and Pollution Research.

[22]  Ting Zhao,et al.  Typical neurobehavioral methods and transcriptome analysis reveal the neurotoxicity and mechanisms of di(2-ethylhexyl) phthalate on pubertal male ICR mice with type 2 diabetes mellitus , 2020, Archives of Toxicology.

[23]  Nicole Jaffrezic-Renault,et al.  New trends in the electrochemical detection of endocrine disruptors in complex media , 2020, Analytical and Bioanalytical Chemistry.

[24]  Rakesh Kumar,et al.  Modified apple polysaccharide capped gold nanoparticles for oral delivery of insulin. , 2020, International journal of biological macromolecules.

[25]  R. Vazquez-Duhalt,et al.  Bi-enzymatic virus-like bionanoreactors for the transformation of endocrine disruptor compounds. , 2020, International journal of biological macromolecules.

[26]  2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020 , 2019, Diabetes Care.

[27]  Jing Liu,et al.  Silicon dioxide nanoparticles induce insulin resistance through endoplasmic reticulum stress and generation of reactive oxygen species , 2019, Particle and Fibre Toxicology.

[28]  M. Cebrián,et al.  Exposure to bisphenol A and diabetes risk in Mexican women , 2019, Environmental Science and Pollution Research.

[29]  A. Marinaccio,et al.  Sub-chronic palladium nanoparticle effects on the endocrine reproductive system of female Wistar rats: Preliminary data , 2019, Toxicology and industrial health.

[30]  G. Ponti,et al.  Metabolism Disrupting Chemicals and Alteration of Neuroendocrine Circuits Controlling Food Intake and Energy Metabolism , 2019, Front. Endocrinol..

[31]  L. Sheppard,et al.  Maternal urinary phthalate metabolites in relation to gestational diabetes and glucose intolerance during pregnancy. , 2019, Environment international.

[32]  M. Saifi,et al.  Therapeutic applications of selenium nanoparticles. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[33]  G. Singh,et al.  The Unprecedented Role of Gold Nonmaterial in Diabetes Management. , 2020, Recent patents on drug delivery & formulation.

[34]  D. Albulescu,et al.  Blood Parathyrin and Mineral Metabolism Dynamics. A clinical analyze , 2018, Revista de Chimie.

[35]  Zhenzhong Zhang,et al.  Self-Regulated Carboxyphenylboronic Acid-Modified Mesoporous Silica Nanoparticles with "Touch Switch" Releasing Property for Insulin Delivery. , 2018, ACS applied materials & interfaces.

[36]  Frank B. Hu,et al.  Global aetiology and epidemiology of type 2 diabetes mellitus and its complications , 2018, Nature Reviews Endocrinology.

[37]  C. Rosenfeld Gut Dysbiosis in Animals Due to Environmental Chemical Exposures , 2017, Front. Cell. Infect. Microbiol..

[38]  Baojian Wu,et al.  Selenium nanoparticles as versatile carriers for oral delivery of insulin: Insight into the synergic antidiabetic effect and mechanism. , 2017, Nanomedicine : nanotechnology, biology, and medicine.

[39]  Krishnan Swaminathan,et al.  Gut Microbiota, Endocrine-Disrupting Chemicals, and the Diabetes Epidemic , 2017, Trends in Endocrinology & Metabolism.

[40]  R. Nogueiras,et al.  Endocrine-disrupting chemicals and the regulation of energy balance , 2017, Nature Reviews Endocrinology.

[41]  P. Zimmet Diabetes and its drivers: the largest epidemic in human history? , 2017, Clinical Diabetes and Endocrinology.

[42]  J. Meeker,et al.  Pregnancy urinary phthalate metabolite concentrations and gestational diabetes risk factors. , 2016, Environment international.

[43]  X. Yang,et al.  Alizarin Complexone Functionalized Mesoporous Silica Nanoparticles: A Smart System Integrating Glucose-Responsive Double-Drugs Release and Real-Time Monitoring Capabilities. , 2016, ACS applied materials & interfaces.

[44]  A. A. Abdel Moneim,et al.  Anti-hyperglycemic activity of selenium nanoparticles in streptozotocin-induced diabetic rats , 2015, International journal of nanomedicine.

[45]  N. Chevalier,et al.  Endocrine disruptors: new players in the pathophysiology of type 2 diabetes? , 2015, Diabetes & metabolism.

[46]  Yun-Chul Hong,et al.  Association of bisphenol A exposure with overweight in the elderly: a panel study , 2015, Environmental Science and Pollution Research.

[47]  B. Tunctan,et al.  Determination of urinary levels of Bisphenol A in a Turkish population , 2014, Environmental Monitoring and Assessment.

[48]  C. Bielajew,et al.  Bisphenol-A: Epigenetic Reprogramming and Effects on Reproduction and Behavior , 2014, International journal of environmental research and public health.